Aghajanian C, Goff B, Nycum LR. et al. Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer. Gynecol Oncol 2015; 139: 10-16 doi:10.1016/j.ygyno.2015.08.004
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.